1. Home
  2. LTRY vs IMCC Comparison

LTRY vs IMCC Comparison

Compare LTRY & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRY
  • IMCC
  • Stock Information
  • Founded
  • LTRY 2015
  • IMCC 1980
  • Country
  • LTRY United States
  • IMCC Israel
  • Employees
  • LTRY N/A
  • IMCC N/A
  • Industry
  • LTRY Computer Software: Prepackaged Software
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • LTRY Technology
  • IMCC Health Care
  • Exchange
  • LTRY Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • LTRY N/A
  • IMCC 5.0M
  • IPO Year
  • LTRY N/A
  • IMCC N/A
  • Fundamental
  • Price
  • LTRY $0.49
  • IMCC $2.23
  • Analyst Decision
  • LTRY
  • IMCC
  • Analyst Count
  • LTRY 0
  • IMCC 0
  • Target Price
  • LTRY N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • LTRY 52.0K
  • IMCC 11.8K
  • Earning Date
  • LTRY 11-29-2024
  • IMCC 11-11-2024
  • Dividend Yield
  • LTRY N/A
  • IMCC N/A
  • EPS Growth
  • LTRY N/A
  • IMCC N/A
  • EPS
  • LTRY N/A
  • IMCC N/A
  • Revenue
  • LTRY $5,723,382.00
  • IMCC $36,445,402.00
  • Revenue This Year
  • LTRY N/A
  • IMCC $22.59
  • Revenue Next Year
  • LTRY N/A
  • IMCC $20.53
  • P/E Ratio
  • LTRY N/A
  • IMCC N/A
  • Revenue Growth
  • LTRY 125.44
  • IMCC N/A
  • 52 Week Low
  • LTRY $0.50
  • IMCC $1.13
  • 52 Week High
  • LTRY $7.01
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • LTRY 34.24
  • IMCC 41.06
  • Support Level
  • LTRY $0.51
  • IMCC $2.02
  • Resistance Level
  • LTRY $0.57
  • IMCC $2.15
  • Average True Range (ATR)
  • LTRY 0.03
  • IMCC 0.14
  • MACD
  • LTRY 0.01
  • IMCC -0.01
  • Stochastic Oscillator
  • LTRY 0.00
  • IMCC 19.15

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: